VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_21-vv-00572
Package ID: USCOURTS-cofc-1_21-vv-00572
Petitioner: H.C.
Filed: 2021-01-11
Decided: 2024-08-02
Vaccine: influenza
Vaccination date: 2019-10-24
Condition: shoulder injury related to vaccine administration (SIRVA)
Outcome: compensated
Award amount USD: 51168

AI-assisted case summary:
H.C., an adult, received an influenza vaccine on October 24, 2019. Within days, she developed pain and limited range of motion in her left shoulder, diagnosed as Shoulder Injury Related to Vaccine Administration (SIRVA). She sought medical treatment for approximately four months, including physical therapy and a cortisone injection, but stopped formal treatment due to time and financial constraints, exacerbated by the onset of the COVID-19 pandemic. She continued to manage her pain with medication and self-care, refilling a prescription for diclofenac nearly ten months after vaccination. She later sought further medical evaluation in July 2022. The court considered medical records, pharmacy records, and affidavits from H.C. and her daughter. Respondent initially contested entitlement, arguing the severity requirement was not met, but later conceded entitlement based on the Table criteria for SIRVA. The Chief Special Master found that the evidence, including contemporaneous medical records and affidavits, preponderantly established that H.C. suffered residual effects for more than six months, satisfying the statutory severity requirement. The case proceeded to damages, and the parties stipulated to an award. H.C. was awarded $51,168.60, comprising $50,500.00 for pain and suffering and $668.60 for past unreimbursable expenses.

Theory of causation field:
Table

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_21-vv-00572-1
Date issued/filed: 2024-07-08
Pages: 12
Docket text: PUBLIC ORDER/RULING (Originally filed: 04/10/2024) regarding 56 Ruling on Entitlement, Order on Motion for Ruling on the Record ( Signed by Chief Special Master Brian H. Corcoran. )(mpj) Service on parties made.
--------------------------------------------------------------------------------
Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 1 of 12
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 21-0572V
H.C., Chief Special Master Corcoran
Petitioner, Filed: April 10, 2024
v. Re-filed as Redacted: July 2, 2024
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
Nicholas Paul Provenzo, Provenzo Law PLLC, Alexandria, VA, for Petitioner.
Lauren Kells, U.S. Department of Justice, Washington, DC, for Respondent.
RULING ON ENTITLEMENT1
On January 11, 2021, H.C. filed a petition for compensation under the National
Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine
Act”). Petitioner alleges that she suffered a shoulder injury related to vaccine
administration (“SIRVA”) resulting from an influenza (“flu”) vaccine received on October
24, 2019. Petition at 1. The case was assigned to the Special Processing Unit of the
Office of Special Masters.
1 When this Ruling was originally filed, I advised my intent to post it on the United States Court of Federal
Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance
with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion
of Electronic Government Services). In accordance with Vaccine Rule 18(b), Petitioner filed a timely motion
to redact certain information. This decision is being posted with Petitioner’s name redacted to reflect her
initials only, as well as the initials only of Petitioner’s adult daughter. Except for those changes and this
footnote, no other substantive changes have been made. This Ruling will be posted on the court’s website
and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc with no further opportunity to move
for redaction.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C.
§ 300aa (2018).

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 2 of 12
For the reasons discussed below, I find that record evidence preponderantly
establishes that Petitioner suffered the residual effects of her injury for more than six
months, and has satisfied the remaining requirements for entitlement.
I. Relevant Procedural History
This case was activated on July 8, 2021 (ECF No. 11). Just under a year later,
Respondent stated that he would defend the case (ECF No. 38), and then filed his Rule
4(c) Report detailing his objections (ECF No. 42). Thereafter, Petitioner filed additional
evidence (ECF No. 48). After reviewing the additional evidence, Respondent stated that
he would not defend the case based on onset or the remaining SIRVA QAI, but continued
to maintain that Petitioner had not met the statutory severity requirement (ECF No. 50).
On April 17, 2023, Petitioner filed a motion for a ruling on the record requesting a finding
that she is entitled to compensation (ECF No. 52). Respondent offered a brief (ECF No.
54), and Petitioner replied (ECF No. 55). The matter of Petitioner’s entitlement to
compensation is now ripe for resolution.
II. Factual Findings and Ruling on Entitlement
A. Legal Standards
Before compensation can be awarded under the Vaccine Act, a petitioner must
demonstrate, by a preponderance of evidence, all matters required under Section
11(c)(1), including the factual circumstances surrounding his or her claim. Section
13(a)(1)(A). In making this determination, the special master or court should consider the
record as a whole. Section 13(a)(1). Petitioner’s allegations must be supported by medical
records or by medical opinion. Id.
To resolve factual issues, the special master must weigh the evidence presented,
which may include contemporaneous medical records and testimony. See Burns v. Sec'y
of Health & Human Servs., 3 F.3d 415, 417 (Fed. Cir. 1993) (explaining that a special
master must decide what weight to give evidence including oral testimony and
contemporaneous medical records). “Medical records, in general, warrant consideration
as trustworthy evidence. The records contain information supplied to or by health
professionals to facilitate diagnosis and treatment of medical conditions. With proper
treatment hanging in the balance, accuracy has an extra premium. These records are
also generally contemporaneous to the medical events.” Cucuras v. Sec’y of Health &
Human Servs., 993 F.2d 1525, 1528 (Fed. Cir. 1993).
To overcome the presumptive accuracy of medical records testimony, a petitioner
may present testimony which is “consistent, clear, cogent, and compelling.” Sanchez v.
Sec'y of Health & Human Servs., No. 11-685V, 2013 WL 1880825, at *3 (Fed. Cl. Spec.
2

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 3 of 12
Mstr. Apr. 10, 2013) (citing Blutstein v. Sec'y of Health & Human Servs., No. 90-2808V,
1998 WL 408611, at *5 (Fed. Cl. Spec. Mstr. June 30, 1998)). The Federal Circuit has
“reject[ed] as incorrect the presumption that medical records are accurate and complete
as to all the patient’s physical conditions.” Kirby v. Sec’y of Health & Human Servs., 997
F.3d 1378, 1383 (Fed. Cir. 2021) (explaining that a patient may not report every ailment,
or a physician may enter information incorrectly or not record everything he or she
observes).
In addition to requirements concerning the vaccination received and the lack of
other award or settlement,3 a petitioner must establish that he or she suffered an injury
meeting the Table criteria, in which case causation is presumed, or an injury shown to be
caused-in-fact by the vaccination he or she received. Section 11(c)(1)(C). The Vaccine
Act further includes a “severity requirement,” pursuant to which a petitioner demonstrate
that they:
(i) suffered the residual effects or complications of such illness, disability,
injury, or condition for more than 6 months after the administration of the
vaccine, or (ii) died from the administration of the vaccine, or (iii) suffered
such illness, disability, injury or condition from the vaccine which resulted in
inpatient hospitalization and surgical intervention.
Section 11(c)(1)(D).
“[T]he fact that a Petitioner has been discharged from medical care does not
necessarily indicate that there are no remaining or residual effects from her alleged
injury.” Morine v. Sec’y of Health & Human Servs., No. 17-1013, 2019 WL 978825, at *4
(Fed. Cl. Spec. Mstr. Jan. 23, 2019); see also Herren v. Sec’y of Health & Human Servs.,
No. 13-1000V, 2014 WL 3889070, at *3 (Fed. Cl. Spec. Mstr. July 18, 2014) (“a discharge
from medical care does not necessarily indicate there are no residual effects”). “A
treatment gap . . . does not automatically mean severity cannot be established.” Law v.
Sec’y of Health & Human Servs., No. 21-0699V, 2023 WL 2641502, at *5 (Fed. Cl. Spec.
Mstr. Feb. 23, 2023) (finding severity requirement met where Petitioner sought care for
under three months and had met physical therapy goals but still lacked full range of motion
and experienced difficulty with certain activities, then returned to care nearly five months
later reporting stiffness and continuing restrictions in motion); see also Peeples v. Sec’y
of Health & Human Servs., No. 20-0634V, 2022 WL 2387749 (Fed. Cl. Spec. Mstr. May
26, 2022) (finding severity requirement met where Petitioner sought care for four months,
followed by fifteen month gap); Silvestri v. Sec’y of Health & Human Servs., No. 19-
1045V, 2021 WL 4205313 (Fed. Cl. Spec. Mstr. Aug. 16, 2021) (finding severity
3 In summary, a petitioner must establish that he received a vaccine covered by the Program, administered
either in the United States and its territories or in another geographical area but qualifying for a limited
exception and has not filed a civil suit or collected an award or settlement for his or her injury. Section
11(c)(1)(A)(B)(E).
3

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 4 of 12
requirement satisfied where Petitioner did not seek additional treatment after the five
month mark.
The most recent version of the Table, which can be found at 42 C.F.R. § 100.3,
identifies the vaccines covered under the Program, the corresponding injuries, and the
time period in which the particular injuries must occur after vaccination. Section 14(a).
Pursuant to the Vaccine Injury Table, a SIRVA is compensable if it manifests within 48
hours of the administration of a flu vaccine. 42 C.F. R. § 100.3(a)(XIV)(B). The criteria
establishing a SIRVA under the accompanying Qualifications and Aids to Interpretation
(“QAI”) are as follows:
Shoulder injury related to vaccine administration (SIRVA). SIRVA manifests
as shoulder pain and limited range of motion occurring after the
administration of a vaccine intended for intramuscular administration in the
upper arm. These symptoms are thought to occur as a result of unintended
injection of vaccine antigen or trauma from the needle into and around the
underlying bursa of the shoulder resulting in an inflammatory reaction.
SIRVA is caused by an injury to the musculoskeletal structures of the
shoulder (e.g. tendons, ligaments, bursae, etc.). SIRVA is not a neurological
injury and abnormalities on neurological examination or nerve conduction
studies (NCS) and/or electromyographic (EMG) studies would not support
SIRVA as a diagnosis (even if the condition causing the neurological
abnormality is not known). A vaccine recipient shall be considered to have
suffered SIRVA if such recipient manifests all of the following:
(i) No history of pain, inflammation or dysfunction of the affected shoulder
prior to intramuscular vaccine administration that would explain the alleged
signs, symptoms, examination findings, and/or diagnostic studies occurring
after vaccine injection;
(ii) Pain occurs within the specified time-frame;
(iii) Pain and reduced range of motion are limited to the shoulder in which
the intramuscular vaccine was administered; and
(iv) No other condition or abnormality is present that would explain the
patient’s symptoms (e.g. NCS/EMG or clinical evidence of radiculopathy,
brachial neuritis, mononeuropathies, or any other neuropathy).
42 C.F.R. § 100.3(c)(10).
A special master may find that the first symptom or manifestation of onset of an
injury occurred “within the time period described in the Vaccine Injury Table even though
the occurrence of such symptom or manifestation was not recorded or was incorrectly
recorded as having occurred outside such period.” Section 13(b)(2). “Such a finding may
4

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 5 of 12
be made only upon demonstration by a preponderance of the evidence that the onset [of
the injury] . . . did in fact occur within the time period described in the Vaccine Injury
Table.” Id.
B. Relevant Factual History
This ruling contains only a brief overview of facts most relevant to the parties’
dispute.
1. Medical Records
A December 2016 record (nearly three years before the vaccination at issue in this
case) lists diclofenac4 as a current medication to be taken as needed for pain, although it
does not specify the nature of the pain or its source. Ex. 3 at 6-7. Petitioner’s pharmacy
records document that she filled two prescriptions for diclofenac three years before
vaccination, on June 21, 2016 and October 31, 2016, as well as two after (November 12,
2019 and August 19, 2020). Ex. 11 at 5.
On October 24, 2019, Petitioner received a flu vaccine in her left arm. Exs. 2; 7 at
1. Although the vaccination record has two different dates of vaccine administration –
October 24 and October 26, 2019 (Ex. 7 at 1-4) – the parties agree, and I find, that a
preponderance of the evidence supports October 24th as the correct date. See, e.g., Ex.
13, Attachment 1 (email from Petitioner’s employer stating that Walmart pharmacy staff
would be onsite on October 24, 2019 providing vaccinations).5
Nineteen days later (November 12, 2019), Petitioner saw her primary care provider
Dr. Sterling Ransone, complaining of left arm pain since her October 24th vaccination at
work. Ex. 3 at 17. She complained of pain at a level of seven out of ten, and had tried
acetaminophen with mild relief. Id. On examination, she had normal range of motion and
her left upper arm was tender. Id. at 20. She was assessed with acute bursitis of her left
shoulder, with Dr. Ransone explaining that her flu vaccination was “given into the bursa
causing inflammation.” Id. He prescribed diclofenac tablets and instructed Petitioner to
return to the office for a cortisone injection if she was not better in a week. Id.
Two weeks later (November 25, 2019), Petitioner returned to Dr. Ransone
requesting a cortisone injection. Ex. 3 at 13. She reported periodic sharp stabbing pain at
a level of eight out of ten. Id. On examination, she had normal range of motion. Id. at 15.
She was again assessed with acute bursitis of the left shoulder, and a cortisone injection
was administered. Id. at 15-16.
4 Diclofenac is a non-steroidal anti-inflammatory drug used to relieve mild to moderate pain. MedlinePlus,
Diclofenac, https://medlineplus.gov/druginfo/meds/a689002.html (last visited April 10, 2024).
5 This is further supported by affidavit evidence supporting a vaccination date of October 24, 2019. Ex. 6 at
¶ 2; Ex. 8 at ¶ 2; Ex. 10 at ¶ 5; Ex. 13 at ¶¶ 2-4.
5

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 6 of 12
An EMG the following month revealed minimal to mild left median neuropathy at
the wrist, but no obvious evidence of active left C5-6 radiculopathy or upper trunk left
brachial plexopathy. Ex. 5 at 8. Petitioner returned to Dr. Ransone to discuss the EMG
results on December 27, 2019. Ex. 3 at 9. The cortisone injection had provided moderate
pain relief, and she rated her pain four out of ten. Id. Dr. Ransone referred her to physical
therapy (“PT”). Id. at 11.
On January 24, 2020, Petitioner underwent a PT evaluation. Ex. 4 at 18. She
reported left shoulder pain that began immediately after the October vaccination. Id. She
had pain, decreased active range of motion, and tingling since that time, and was
experiencing difficulty lifting items, and was unable to sleep comfortably on her left side.
Id. The cortisone injection had helped, but she was concerned about how long her injury
had lasted. Id. Her pain level was three out of ten, ranging to four at worst. Id. On
examination, her left shoulder active range of motion was 145 degrees in flexion
(compared to 164 degrees on the right), 130 degrees in abduction (compared to 165
degrees on the right), and 40 degrees in extension (compared to 70 degrees on the right).
Id. at 19. She was advised to attend two PT sessions a week for 12 weeks. Id. at 20.
Petitioner attended two more PT sessions, on February 10 and February 12, 2020.
Ex. 4 at 23-26. At her last session (February 12th) she continued to report pain along the
posterior aspect of her shoulder and into the lateral aspect of the glenohumeral joint. Id.
at 25. She also complained of decreased active range of motion, and difficulty lifting things
and sleeping on her left side. Id. She tolerated treatment well, with improving range of
motion and decreasing inflammation. Id. She was able to do new activities with some
discomfort but no increase in pain. Id. Due to her schedule, she was unable to attend
treatment regularly, which reduced its effectiveness. Id.
Petitioner cancelled her next three PT appointments. Ex. 4 at 27-29. Then, on
February 24, 2020, she cancelled all remaining appointments, explaining that she did not
have time for PT, and that it was “starting to cost her a lot of money.” Id. at 29. She was
discharged that day, with the therapist noting that minimal progress had been made
because Petitioner attended only two treatments.6 Id. at 30-32.
Over six months later, on August 19, 2020, Petitioner refilled her diclofenac
prescription. Ex. 11 at 2, 5. There are no records of further medical treatment – for her
shoulder or anything else – until nearly two years later.
On July 13, 2022, Petitioner saw nurse practitioner (“NP”) Carla Rothmann,
complaining of left shoulder pain that began after a flu vaccination in 2019. Ex. 12 at 4.
She reported that the injection site was still painful to touch and that she did not feel like
she had regained full range of motion. Id. On examination, her left posterior deltoid was
6 Including the date of her evaluation, Petitioner attended three PT sessions: January 24, February 10, and
February 12, 2020. Ex. 4 at 18, 23, 25.
6

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 7 of 12
tender to palpation and had mild pain with range of motion. Id. at 7. She was assessed
with SIRVA and chronic bursitis of her left shoulder. Id. The next day, she called asking
about medication for her shoulder pain. Id. at 2. NP Rothmann stated that she could try
Voltaren gel. Id. No other medical records have been filed.
2. Affidavits
Petitioner filed five affidavits in support of her claim. Exs. 6, 8, 9, 10, 13. Petitioner
is a registered nurse employed by a public school system in Virginia. Ex. 6 at ¶¶ 17, 18.
She states that her injury left her unable to carry groceries, laundry, or fasten her seat
belt for six months. Id. at ¶ 11. Her injury impacted her daily activities such as getting
dressed, bathing, brushing her hair and teeth, preparing meals, washing dishes,
completing household chores, using her elliptical exercise trainer, and caring for her three
dogs. Id. at ¶ 12.
Petitioner has stated that she stopped PT after one month due to financial burdens
stemming from her situation as a single mother of a college-age student who relied on
her for financial support, and the uncertainty surrounding her employment in light of the
economic impact of the COVID-19 Pandemic. Ex. 6 at ¶ 17; Ex. 13 at ¶ 6. Her employer,
a public school system, ceased all in-person activities on March 13, 2020 in compliance
with an order issued by the Governor of Virginia. Ex. 6 at ¶ 7. She was at heightened risk
from COVID-19 due to her age and body mass, and thus self-quarantined and limited
outside contact. Ex. 13 at ¶¶ 8-10. She self-treated with exercises, stretching, ice, and
heat at home. Id. at ¶¶ 11-12.
Petitioner explained that Dr. Ransone prescribed diclofenac for pain. Ex. 9 at ¶ 3.
Because she experienced negative side effects, including nausea, from the medication,
she did not take it daily and used other methods to manage her pain such as over the
counter pain medications, topical ointments, and stretches she learned during PT. Id. at
¶¶ 5-6.
Petitioner’s daughter, C.P., submitted an affidavit in support of Petitioner’s claim.
Ex. 10. Ms. P. received a flu vaccine at the same date and location as her mother. Id. at
¶ 5. Almost immediately after vaccination, her mother said words to the effect that she
“[didn’t] think he did that right, my arm, it hurts.” Id. at ¶ 6. A few days later, presuming
that the pain had gone away, Ms. P. gave her mother a hug good night, and her mother
screamed in pain. Id. at ¶¶ 12-15. After that, Ms. P. began accommodating her mother’s
shoulder pain, only giving her hugs on her uninjured side to avoid aggravating her
shoulder pain. Id. at ¶¶ 18-19.
Ms. P. lived with her mother until August 15, 2020, when she left for college. Ex.
10 at ¶ 20. During that time, she observed that her mother was unable to clean, cook, or
perform ordinary life tasks due to pain. Id. at ¶ 21. Her mother could no longer lift things
such as laundry, trash, and groceries, and her mobility was restricted, due to pain. Id. at
7

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 8 of 12
¶¶ 22-23. Petitioner could no longer walk her dogs, and her mental well-being was
negatively impacted, due to pain. Id. at ¶¶ 24-25. Ms. P. observed her mother taking pain
medication during this time. Id. at ¶ 26.
C. The Parties’ Arguments
Petitioner argues that the medical records and affidavit evidence demonstrate that
her symptoms continued for more than six months, and thus the statutory severity
requirement is satisfied. Petitioner’s Motion for a Ruling on the Record, filed April 17,
2023, at *11-18 (ECF No. 52) (“Mot.”). These records demonstrate that she sought care
until February 2020, after which she made the decision to forego additional PT and self-
treat her injury in light of the uncertainty surrounding the COVID-19 Pandemic. Mot. at
*14-15. She refilled her pain medication nearly ten months after the onset of her injury,
and then (albeit much later) again sought medical care in July 2022. Id.
Petitioner argues that this case is distinguishable from Lett v. Sec’y of Health &
Human Servs., 39 Fed. Cl 259, 260 (1997). Lett merely held that a petitioner’s statement
alone is insufficient to prove that a seizure occurred. Mot. at *13. Here, by contrast,
Petitioner’s later medical records also document the symptoms at issue. Id. (citing Ray v.
Sec’y of Health & Human Servs., No. 16-1388V, 2018 WL 7051571 (Fed. Cl. Spec. Mstr.
Dec. 17, 2018), and Gear v. Sec’y of Health & Human Servs., No. 18-1684V, 2020 WL
5407825, at *9 (Fed. Cl. Spec. Mstr. Aug. 20, 2020)). Petitioner argues that the Federal
Circuit has determined that sworn testimony as to facts within an individual’s personal
knowledge – even the person pursuing compensation for a vaccine-related injury – can
represent objective evidence on such factual issues. Id. (citing James-Cornelius v. Sec’y
of Health & Human Servs., 984 F.3d 1374, 1380 (Fed. Cir. 2021)).
Petitioner acknowledges that her affidavits cannot alone establish her right to
compensation, but argues they should be considered within the context of other evidence
– which La Londe v. Sec’y of Health & Human Servs., 110 Fed. Cl. 184, 204 (2013), aff’d,
746 F. 3d 1335 (Fed. Cir. 2014), states should be fully considered. Mot. at *14. Petitioner
adds that pursuant to Burns v. Sec’y of Health & Human Servs., 3 F.3d 415, 417 (Fed.
Cir. 1993), it is within a special master’s discretion whether to afford greater weight to
medical records or to other records, such as oral testimony, provided that the
determination is rational. Id. Petitioner urges the use of a flexible and non-technical
approach to evaluating evidence, citing Cucuras v. Sec’y of Health & Human Servs., 993
F.2d 1525 (Fed. Cir. 1993). Id. at *15. Petitioner argues that I should assess the totality
of the evidence, including the July 2022 record and all other medical records, pharmacy
records, and affidavits. Id. at *16-17.
Respondent argues that the severity requirement is not satisfied, noting that
Petitioner sought treatment for less than four months. Response to Motion for Ruling on
the Record, filed June 1, 2023, at *5 (ECF No. 54) (“Resp.”). A special master, he
contends, may not make a finding based on the claims of a petitioner alone, citing Lett.
8

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 9 of 12
Resp. at *5. Respondent argues that in Kirby v. Sec’y of Health & Human Servs., 997
F.3d 1378 (Fed. Cir. 2021), the Federal Circuit affirmed several important points from
Cucuras, including that “oral testimony in conflict with contemporaneous documentary
evidence deserves little weight,” and that medical records are generally “trustworthy”
because they “contain information supplied to or by health professionals to facilitate
diagnosis and treatment of medical conditions,” where “accuracy has an extra premium.”
Id. at *6 (citing Kirby, 997 F.3d at 1382).
Respondent further argues that to overcome information in contemporaneous
medical records, oral or written testimony must be “consistent, clear, cogent, and
compelling.” Resp. at *6-7 (citing Camery v. Sec’y of Health & Human Servs., 42 Fed. Cl.
391 (1988)). Respondent argues that in this case, Petitioner’s testimony is not sufficiently
compelling to overcome the contemporaneous medical records. Id. at *7. Although
Petitioner cites the COVID-19 Pandemic and related financial burdens to explain stopping
formal PT, Petitioner’s last PT session was on February 12, 2020 – an entire month before
the March 13, 2020 order suspending in-person schooling. Id. And the PT records indicate
that she stopped PT because she did not have time and it was costing her too much
money, which Respondent views as “inconsistent with petitioner’s claim that the
pandemic was the driving force behind her decision to stop attending PT.” Id.
Respondent adds that Petitioner has not provided evidence that her PT provider
was affected by the Virginia Governor’s order suspending in-person schooling, and has
not provided evidence as to whether virtual PT was possible. Resp. at *7. While Petitioner
states she continued to do her exercises and stretching at home, she has provided no
objective evidence in support of these claims beyond her word alone. Id.
Although Petitioner refilled her diclofenac prescription in August 2020, this was
nearly six months after her final PT visit. Resp. at *7. And the only evidence that Petitioner
continued to take her medication for pain related to her SIRVA is her own subjective
statements and those of her daughter, provided over two years after vaccination for
purposes of litigation. Id. at *8. While Petitioner sought formal medical care for her
shoulder condition again in July 2022, this was only after Respondent indicated his intent
to defend this case. Id. at *8 n.3. Furthermore, Petitioner had taken diclofenac prior to
vaccination, and had periodic left knee pain and carpal tunnel syndrome – suggesting
that she could have needed diclofenac in August 2020 for reasons other than left shoulder
pain. Id. at *8.
Respondent argues that affidavits can be insufficient to establish that the six-month
requirement has been met. Resp. at *8 (citing Delzer v. Sec’y of Health & Human Servs.,
No. 17-462V, 2019 WL 994582 (Fed. Cl. Spec. Mstr. Jan. 18, 2019); Uetz v. Sec’y of
Health & Human Servs., No. 14-29V, 2014 WL 7139803 (Fed. Cl. Spec. Mstr. Nov. 21,
2014); Vogler v. Sec’y of Health & Human Servs., No. 11-424V, 2014 WL 1991851 (Fed.
Cl. Spec. Mstr. Apr. 25, 2014)). Respondent acknowledges that these rulings are not
9

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 10 of 12
binding on the outcome of this matter, but asserts that Petitioner has “provided no
compelling reason that this Court should diverge from the holdings therein.” Id. at *8-9.
Petitioner replies that the COVID-19 Pandemic “significantly impacted the
petitioner’s access to medical treatment, influencing her decision-making during this
period.” Petitioner’s Reply, filed June 8, 2023, at *2 (ECF No. 55) (“Reply”). The
Pandemic’s impact on healthcare services was felt before the March 13, 2020 order
closing in-person schooling. Reply at *2. The “escalating threat of the pandemic was
already disrupting healthcare services and increasing the risk of infection in these
settings.” Id. Petitioner argues that it is unfair to suggest that Petitioner would develop
worries about the economic impact of the COVID-19 impact only after the March 13, 2020
suspension of in-person schooling. Id. at *2-3. As a registered nurse, Petitioner had the
knowledge and skills to self-treat proactively. Id. at *3.
Petitioner also argues that her pharmacy records provide evidence of a clear
correlation between the dates she filled her diclofenac prescription and her diagnoses
related to her shoulder injury. Reply at *4. Her affidavits “offer a consistent, clear, cogent
and compelling narrative of her sustained symptoms” consistent with Camery, 42 Fed. Cl.
at 395. Id. And for many medical symptoms, a patient’s testimony may be the best, or
only, direct evidence of their occurrence. Id. at *5 (citing James-Cornelius, 984 F.3d
1374). Petitioner’s “reliance on affidavits arose from the extraordinary circumstances of
the COVID-19 Pandemic, not from a deficiency in demonstrating sustained injury.” Id.
Finally, Petitioner references Andreu v. Sec’y of Health & Human Servs., 569 F.3d
1367, 1379 (Fed. Cir. 2009), noting that it instructs that the credibility of the person
offering testimony is a crucial factor. Reply at *7. And she asserts that her professional
background as a registered nurse “enhances her credibility and bolsters her claims
regarding her symptoms and self-treatment.” Id. Petitioner views Respondent’s position
as “overly restrictive and fail[ing] to consider the totality of the evidence.” Id.
D. Factual Finding Regarding QAI Criteria for Table SIRVA
Respondent does not contest the four primary SIRVA QAI criteria, and I find that
they are satisfied. There is no evidence that Petitioner had a pre-vaccination left shoulder
condition, or another condition or abnormality, that would explain her symptoms after
vaccination. Ex. 3. The onset of her shoulder pain most likely occurred within 48 hours of
vaccination. Exs. 3 at 17; 4 at 18; 6; 10; 13. And her symptoms were limited to her left
shoulder, where she received the flu vaccine. Exs. 3, 4.
E. Statutory Severity Requirement
I find that preponderant evidence supports a finding that the statutory severity
requirement is satisfied – although the overall record does not establish a severe SIRVA,
and therefore damages awarded in this case will not be substantial.
10

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 11 of 12
To demonstrate that she suffered residual effects for at least six months, Petitioner
must establish that her symptoms continued until late April 2020. Petitioner treated her
shoulder injury until February 12, 2020 – close to four months. At her final PT session on
February 12th, she continued to report pain. Ex. 4 at 25. Her range of motion was
improving, but still decreased. Id. And she still had difficulty lifting things and sleeping on
her left side. Id. Thus, the written record does not establish that she was discharged due
to lack of symptoms, but instead stopped PT due to time and financial constraints.7
Thereafter, there is support for the finding that Petitioner continued to treat with
diclofenac and self-care. Exs. 6, 9, 10, 13. She refilled her diclofenac prescription in
August 2020, just under ten months after vaccination, supporting her claim that she
continued to experience shoulder pain during this time period. Ex. 11 at 2, 5. Admittedly,
there was then a lengthy gap in treatment – and it tends to undermine the conclusion that
Petitioner’s SIRVA continued to linger, without formal efforts at treatment, through mid-
2022. But for present purposes, a finding of severity merely through April 2020 is
sufficient, and the record does support such a finding.
Contrary to Respondent’s suggestion, this is not a case involving a conflict
between medical records and testimonial evidence, and Petitioner does not seek to use
affidavit evidence to overcome inconsistent medical record evidence. Instead, Petitioner’s
affidavit evidence complements and is bolstered by the medical record evidence.
Together, they preponderate in favor of a finding that Petitioner’s shoulder pain continued
for over six months. Thus, in ruling in Petitioner’s favor on the severity issue, I am not
relying on the claims of Petitioner alone; the affidavits are consistent with and supported
by medical record evidence.
The cases cited by Respondent are not persuasive. Delzer involved a petitioner
who treated for nearly four months – but then continued PT for a clearly different condition
for over two years without complaining of left shoulder pain. Delzer, 2019 WL 994582, at
*2. This is in stark contrast to Ms. C., who did not seek any other medical care during the
time in question.
Similarly, the petitioner in Uetz only sought care for her alleged vaccine-related
injury for a matter of days, and sought to demonstrate that her symptoms continued for
more than six months through affidavits and a medical record created over a year and a
half later that the special master found appeared to have been prepared for litigation.
Uetz, 2014 WL 7139803, at *1-2, 4. In contrast, Ms. C. treated for nearly four months
before stopping. And contemporaneous medical records indicated that the Vogler
7 I do not find, however, that the impositions of the COVID-19 Pandemic deserve much weight herein in
resolving severity, since the record shows Petitioner’s decision to cease treatment occurred before mid-
March 2020 – and that this decision was not based on an inability to obtain treatment due to Pandemic-
related concerns (although there is some evidence Pandemic concerns motivated Petitioner to avoid going
back to treatment in the spring of 2020).
11

Case 1:21-vv-00572-UNJ Document 70 Filed 07/08/24 Page 12 of 12
petitioner’s condition “had largely resolved” by four months after vaccination, after which
he did not seek care again until almost a year later. Vogler, 2014 WL 1991851, at *9. In
contrast, Ms. C.’s last PT session documents that her condition was not resolved, and the
therapist stated that she had made minimal progress because she had not attended more
sessions. And she refilled her diclofenac – which was prescribed to her for her shoulder
pain – several months later, supporting a finding that her pain persisted.
A petitioner who seeks care for less than four months will not always be able to
satisfy the statutory severity requirement. However, in the particular circumstances of this
case, I find that the requirement is met. Of course, the limited duration and amount of
treatment Petitioner sought, and the significant treatment gaps, suggest that her
symptoms were not particularly severe. Petitioner should expect a very modest pain and
suffering award (and to that end should not protract this case unreasonably in the hope
of a higher sum).
F. Other Requirements for Entitlement
The record contains preponderant evidence that other requirements for entitlement
are satisfied as well. Petitioner received a covered vaccine in the United States. Exs. 2,
7. She averred that she has never received an award or settlement, or filed a civil action,
for her vaccine-related injuries. Ex. 6 at ¶¶ 19, 20.
Conclusion
Based on my review of the record as a whole, I find that it is more likely than not
that all SIRVA Table requirements are met. I find that the statutory severity requirement
is satisfied by preponderant evidence, as are other requirements for entitlement.
Therefore, Petitioner’s motion for a ruling on the record that she is entitled to
compensation is GRANTED.
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
12

================================================================================
DOCUMENT 2: USCOURTS-cofc-1_21-vv-00572-2
Date issued/filed: 2024-08-02
Pages: 5
Docket text: PUBLIC DECISION (Originally filed: 06/24/2024) regarding 67 DECISION Stipulation/Proffer, Signed by Chief Special Master Brian H. Corcoran. (ppa) Service on parties made.
--------------------------------------------------------------------------------
Case 1:21-vv-00572-UNJ Document 73 Filed 08/02/24 Page 1 of 5
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 21-0572V
H.C., Chief Special Master Corcoran
Petitioner, Filed: June 24, 2024
v.
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
Nicholas Paul Provenzo, Provenzo Law PLLC, Alexandria, VA, for Petitioner.
Lauren Kells, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION AWARDING DAMAGES1
On January 11, 2021, H.C. filed a petition for compensation under the National
Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine
Act”). Petitioner alleges that she suffered a shoulder injury related to vaccine
administration (“SIRVA”) resulting from an influenza (“flu”) vaccine received on October
24, 2019. Petition at 1. The case was assigned to the Special Processing Unit of the
Office of Special Masters.
On April 10, 2024, a ruling on entitlement was issued, finding Petitioner entitled to
compensation for SIRVA. On June 24, 2024, Respondent filed a proffer on award of
compensation (“Proffer”) indicating Petitioner should be awarded $51,168.60. Proffer at
2.In the Proffer, Respondent represented that Petitioner agrees with the proffered award.
Id. Based on the record as a whole, I find that Petitioner is entitled to an award as stated
in the Proffer.
1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made
publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or
at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government
Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government
Services). This means the Decision will be available to anyone with access to the internet. In
accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other
information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I
agree that the identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C.
§300aa (2018).

Case 1:21-vv-00572-UNJ Document 73 Filed 08/02/24 Page 2 of 5
Pursuant to the terms stated in the attached Proffer, I award Petitioner a lump
sum payment of $51,168,60 (comprised of $50,500.00 in pain and suffering and past
unreimbursable expenses of $668.60) in the form of a check payable to Petitioner.
This amount represents compensation for all damages that would be available under
Section 15(a).
The Clerk of Court is directed to enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:21-vv-00572-UNJ Document 73 Filed 08/02/24 Page 3 of 5
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
)
H.C., )
)
Petitioner, )
) No. 21-572V
v. ) Chief Special Master Corcoran
) ECF
SECRETARY OF HEALTH AND HUMAN )
SERVICES, )
)
Respondent. )
)
RESPONDENT’S PROFFER ON AWARD OF COMPENSATION
On January 11, 2021, Haley C. Cardwell (“petitioner”) filed a petition for compensation
under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-1 to -34
(“Vaccine Act” or “Act”), alleging that she suffered a Shoulder Injury Related to Vaccine
Administration (“SIRVA”), as defined in the Vaccine Injury Table, following administration of
an influenza vaccine she received on October 24, 2019. Petition at 1. On September 2, 2022, the
Secretary of Health and Human Services (“respondent”) filed a Rule 4(c) Report recommending
that the Court dismiss the petition. Thereafter, the Court ordered the parties to submit briefs
regarding entitlement, and on April 10, 2024, the Chief Special Master issued a Ruling on
Entitlement finding petitioner entitled to compensation for her SIRVA.1 ECF No. 52
(Petitioner’s Motion for a Ruling on the Record); ECF No. 54 (Respondent’s Response to
Petitioner’s Motion for a Ruling on the Record); ECF 56 (Ruling on Entitlement).
1 Respondent has no objection to the amount of the proffered award of damages set forth herein.
Assuming the Chief Special Master issues a damages decision in conformity with this proffer,
respondent waives his right to seek review of such damages decision. However, respondent
reserves his right, pursuant to 42 U.S.C. § 300aa-12(e), to seek review of the Chief Special
Master’s April 10, 2024, entitlement ruling.

Case 1:21-vv-00572-UNJ Document 73 Filed 08/02/24 Page 4 of 5
I. Items of Compensation
A. Pain and Suffering
Respondent proffers that petitioner should be awarded $50,500.00 in pain and suffering.
See 42 U.S.C. § 300aa-15(a)(4). Petitioner agrees.
B. Past Unreimbursable Expenses
Evidence supplied by petitioner documents the expenditure of past unreimbursable
expenses related to her vaccine-related injury. Respondent proffers that petitioner should be
awarded past unreimbursable expenses in the amount of $668.60. See 42 U.S.C. § 300aa-
15(a)(1)(B). Petitioner agrees.
These amounts represent all elements of compensation to which petitioner is entitled
under 42 U.S.C. § 300aa-15(a). Petitioner agrees.
II. Form of the Award
Petitioner is a competent adult. Evidence of guardianship is not required in this case.
Respondent recommends that the compensation provided to petitioner should be made through a
lump sum payment as described below and requests that the Chief Special Master’s decision and
the Court’s judgment award the following2: a lump sum payment of $51,168.60, in the form of a
check payable to petitioner.
III. Summary of Recommended Payments Following Judgment
Lump sum payable to petitioner, Haley C. Cardwell: $51,168.60
Respectfully submitted,
BRIAN M. BOYNTON
Principal Deputy Assistant Attorney General
2 Should petitioner die prior to entry of judgment, the parties reserve the right to move the Court
for appropriate relief. In particular, respondent would oppose any award for future lost earnings
and future pain and suffering.
2

Case 1:21-vv-00572-UNJ Document 73 Filed 08/02/24 Page 5 of 5
C. SALVATORE D’ALESSIO
Director
Torts Branch, Civil Division
HEATHER L. PEARLMAN
Deputy Director
Torts Branch, Civil Division
COLLEEN C. HARTLEY
Assistant Director
Torts Branch, Civil Division
/s/ Lauren Kells
LAUREN KELLS
Trial Attorney
Torts Branch, Civil Division
U.S. Department of Justice
P.O. Box 146
Benjamin Franklin Station
Washington, D.C. 20044-0146
Tel: (202) 616-4187
Email: lauren.kells@usdoj.gov
DATED: June 24, 2024
3